CRNX - Crinetics Pharmaceuticals EPS beats by $0.08 beats on revenue March, 09 2020 04:17 PM Crinetics Pharmaceuticals Inc. Crinetics Pharmaceuticals (NASDAQ:CRNX): Q4 GAAP EPS of -$0.60 beats by $0.08.More news on: Crinetics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...